Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 7, 2022 | Entact Bio Emerges With $81M to Play Matchmaker to Protein-Enhancing Drugs | Small molecules are a mainstay of drug therapy, many of them working by targeting a protein and blocking it. A newer but still experimental approach leads to the degradation of disease-causing proteins. Research has revealed new insights in... |
| Dec 6, 2022 | 4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement | |
| Jun 3, 2015 | Pritzker Group Private Capital Acquires Entact | Pritzker Group Private Capital acquired Entact, a Westmont, Ill.-based provider of environmental remediation services to the private sector, from Austin Ventures and TGF Management Corp. The amount of the deal was not disclosed. Entact’s ma... |
Reviews 0
FAQ about ENTACT, LLC
When was ENTACT, LLC founded?
ENTACT, LLC was founded in 1991.
What has the press written about ENTACT, LLC?
Parsers VC has collected 4 articles mentioning ENTACT, LLC, among them “Entact Bio Emerges With $81M to Play Matchmaker to Protein-Enhancing Drugs” (Dec 7, 2022) and “4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement” (Dec 6, 2022).
Is ENTACT, LLC still active?
Yes, ENTACT, LLC is active; its latest activity on Parsers VC dates from Dec 7, 2022.